<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Cure - Cell and Gene Therapeutics</title>
    <link>https://wewillcure.com/insights/cell-and-gene-therapeutics</link>
    <description>Latest content from Cure in Cell and Gene Therapeutics</description>
    <language>en</language>
    <lastBuildDate>Mon, 16 Mar 2026 12:17:10 GMT</lastBuildDate>
    <atom:link href="https://wewillcure.com/insights/cell-and-gene-therapeutics/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <guid>https://wewillcure.com/insights/company-profiles/cell-and-gene-therapeutics/cell-and-gene-therapy-companies-to-watch-in-2026</guid>
      <title><![CDATA[13 Cell and Gene Therapy Companies to Watch in 2026]]></title>
      <link>https://wewillcure.com/insights/company-profiles/cell-and-gene-therapeutics/cell-and-gene-therapy-companies-to-watch-in-2026</link>
      <description><![CDATA[A look at 13 startups and public companies advancing genetic medicines, cell-based therapies, and next-generation treatment platforms.]]></description>
      <pubDate>Thu, 18 Dec 2025 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/7gFQuxkraYzTI8pd9AUpam/834ea8066001b3880c416856331f4512/Cell_and_Gene_Therapy_copy__1_.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/rare-diseases/federal-gene-therapy-program-expands-access-sickle-cell</guid>
      <title><![CDATA[New Federal Program Expands Access to Gene Therapies for Sickle Cell and More]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/rare-diseases/federal-gene-therapy-program-expands-access-sickle-cell</link>
      <description><![CDATA[CMS’s new Cell and Gene Therapy Access Model allows states to offer sickle cell gene therapies through federally negotiated contracts, reshaping CGT market for startups and rare disease therapeutics.

]]></description>
      <pubDate>Mon, 21 Jul 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/1Vur3DAWr40H7vptQ64t3O/bbffe85e3abd685529af9f7c5f098f61/GettyImages-2183708461.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/oncology/fda-lifts-key-barriers-to-immunotherapies-access-signaling-regulatory-shift</guid>
      <title><![CDATA[FDA Lifts Key Barriers to Immunotherapies Access, Signaling Regulatory Shift]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/oncology/fda-lifts-key-barriers-to-immunotherapies-access-signaling-regulatory-shift</link>
      <description><![CDATA[In a move praised by advocates and physicians, the FDA eliminated post-treatment safety restrictions for CAR T therapies based on real-world data, potentially setting a precedent for regulatory flexibility for cell and gene therapies.]]></description>
      <pubDate>Mon, 07 Jul 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3GwlGne0iF8EUa9KIIkwJk/03491a17ade57ad1ac768f8a1351ffef/GettyImages-961210118.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/rare-diseases/fda-faster-cell-gene-therapy-reviews</guid>
      <title><![CDATA[FDA Industry Panel Pushes for Faster Cell and Gene Therapy Reviews]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/rare-diseases/fda-faster-cell-gene-therapy-reviews</link>
      <description><![CDATA[The FDA held a listening session with cell and gene therapy scientists, advocates and entrepreneurs to learn how to improve the regulatory process.]]></description>
      <pubDate>Fri, 13 Jun 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/7aod0qAmV7ofPgaRetAYDf/b0a30b3c463aec3031de0a77332ef568/GettyImages-2196144750.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/therapeutics/cell-and-gene-therapeutics/proposed-mrna-bans-alarm-scientists-and-startups</guid>
      <title><![CDATA[Proposed mRNA Bans Alarm Scientists and Startups]]></title>
      <link>https://wewillcure.com/insights/therapeutics/cell-and-gene-therapeutics/proposed-mrna-bans-alarm-scientists-and-startups</link>
      <description><![CDATA[A growing number of state legislatures are proposing laws that would limit and even criminalize mRNA medicines, just as the technology is starting to provide new approaches to diseases ranging from ALS to MD and from pancreatic cancer and HIV/AIDS. ]]></description>
      <pubDate>Wed, 14 May 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/cocoCQbeK23g9tY1991P9/9cf7ad69e8900fbfa75f567ada3ac7c1/GettyImages-1488896332.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/despite-twice-the-fda-success-rate-gene-therapies-still-miss-patients</guid>
      <title><![CDATA[Despite Twice the FDA Success Rate, Gene Therapies Still Miss Patients]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/despite-twice-the-fda-success-rate-gene-therapies-still-miss-patients</link>
      <description><![CDATA[A new analysis finds that cell and gene therapies are twice as likely to win FDA approval, but commercial uptake remains slow due to cost, infrastructure and delivery challenges.]]></description>
      <pubDate>Mon, 14 Apr 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/57zoJ7KgBc1esjs26O7IiF/8bdedf91853d2331c41d3a9507365fef/GettyImages-2160639954-2.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/rare-diseases/how-beam-therapeutics-success-could-drive-precision-medicine</guid>
      <title><![CDATA[How Beam Therapeutics Success Could Drive Precision Medicine]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/rare-diseases/how-beam-therapeutics-success-could-drive-precision-medicine</link>
      <description><![CDATA[Beam’s clinical trial is the first to report evidence that a base-editing therapy can rewrite a patient’s genetic code to correct a disease-causing mutation. This milestone now creates a path forward to treat other genetic diseases.]]></description>
      <pubDate>Tue, 18 Mar 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/6PqrJqGEjNqhsKax8Vy7bu/6d713e41630ebed421483ffdf30f4daa/thumbnail_genome_lungs_poly_structure_GTY2160558778.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/rare-diseases/cell-and-gene-therapeutics/duchenne-muscular-dystrophy-treatment-in-transformation</guid>
      <title><![CDATA[Duchenne Muscular Dystrophy Treatment In Transformation]]></title>
      <link>https://wewillcure.com/insights/rare-diseases/cell-and-gene-therapeutics/duchenne-muscular-dystrophy-treatment-in-transformation</link>
      <description><![CDATA[Gene therapy, next-generation steroids, and muscle-protective treatments are among the innovations offering patients with the rare disease Duchenne muscular dystrophy new therapeutic options.]]></description>
      <pubDate>Wed, 26 Feb 2025 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/5Bu08ugdDB5Dva9QvPlh9h/78de984f6daaf6785d794ed61cb67e4c/thumbnail_tetraplegic_boy_GTY1475118869.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/ai-and-machine-learning/biocurie-leads-ai-powered-biomanufacturing-revolution</guid>
      <title><![CDATA[BioCurie Leads AI-Powered Biomanufacturing Revolution]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/ai-and-machine-learning/biocurie-leads-ai-powered-biomanufacturing-revolution</link>
      <description><![CDATA[BioCurie is harnessing AI to optimize the production of cell, gene, and RNA therapies, significantly transforming the economic landscape of advanced therapeutics.]]></description>
      <pubDate>Fri, 21 Feb 2025 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/4ZHpVNcHe4Lf1Xwxvn3Bjb/adb60d99abf3cbd8f3cd8c9682012774/thumbnail_biocure_team_photo.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/therapeutics/oncology/new-book-chronicles-journey-behind-life-saving-medicines</guid>
      <title><![CDATA[New Book Chronicles Journey Behind Life-Saving Medicines]]></title>
      <link>https://wewillcure.com/insights/therapeutics/oncology/new-book-chronicles-journey-behind-life-saving-medicines</link>
      <description><![CDATA[With compelling narratives and expert insights, Pao’s book "Breakthrough: The Quest for Life-Changing Medicines" offers readers a rare glimpse into the intersection of science, perseverance, and human impact.]]></description>
      <pubDate>Wed, 29 Jan 2025 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3PVW5OMD9jYA47eluY7MQf/fce6a414e76d973ee123174f328f9e3e/thumbnail_william_pao_breakthrough_book_cover.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/neurological-health/lexeo-applies-gene-therapy-to-alzheimers-and-heart-diseases</guid>
      <title><![CDATA[Lexeo Applies Gene Therapy to Alzheimer’s and Heart Diseases]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/neurological-health/lexeo-applies-gene-therapy-to-alzheimers-and-heart-diseases</link>
      <description><![CDATA[Lexeo Therapeutics is innovating not just genetic modifications as therapies for target diseases, but also manufacturing and clinical studies.]]></description>
      <pubDate>Wed, 08 Jan 2025 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3xXzIvvpqNq5aHD2M0fY5X/182dc5397a4211c177341e86333a8ffa/thumbnail_dna_helix_human_heart_GTY1585152050.webp" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/rare-diseases/cell-and-gene-therapeutics/spotlight-on-2024-biogeneius-challenge-winner-yifan-ding</guid>
      <title><![CDATA[Spotlight on 2024 BioGENEius Challenge Winner: Yifan Ding]]></title>
      <link>https://wewillcure.com/insights/rare-diseases/cell-and-gene-therapeutics/spotlight-on-2024-biogeneius-challenge-winner-yifan-ding</link>
      <description><![CDATA[Developing and validating a novel gene switch, "TREAD," to enhancing CRISPR-based therapies earned high schooler Yifan Ding top honors in the 2024 BioGENEius Challenge.]]></description>
      <pubDate>Fri, 08 Nov 2024 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/1tlbrqjiEKJdJ2yVJ83wUK/b98f934ceadc0929a1071d7ee0cb96d3/bioGENEius_finalist_yifan_ding.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/founder-stories/lexeo-therapeutics-revolutionizing-genetic-medicine-for-cardiovascular-and</guid>
      <title><![CDATA[Lexeo Therapeutics: Revolutionizing Genetic Medicine for Cardiovascular and Neurodegenerative Diseases ]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/founder-stories/lexeo-therapeutics-revolutionizing-genetic-medicine-for-cardiovascular-and</link>
      <description><![CDATA[Lexeo Therapeutics is developing pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease.]]></description>
      <pubDate>Wed, 18 Sep 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/26nhPSDw7uhz9OuNcJb70h/89d35896042bac4507904fc2cfe0ecda/241809_genetic_therapy_development_thumbnail_1920x1080.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/oncology/cell-and-gene-therapeutics/mvp-insights_article-leveraging-car-t-therapy-to-tackle-acute-myeloid</guid>
      <title><![CDATA[Leveraging CAR T Therapy to Tackle Acute Myeloid Leukemia]]></title>
      <link>https://wewillcure.com/insights/oncology/cell-and-gene-therapeutics/mvp-insights_article-leveraging-car-t-therapy-to-tackle-acute-myeloid</link>
      <description><![CDATA[For his work developing the CAR T therapy, Sascha Haubner, MD, was named a 2023-2024 recipient of the ASH Peter Steelman Scholar Award.]]></description>
      <pubDate>Wed, 05 Jun 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/2TpYGbm8THWWpk3UVNmUAc/8e3cbe7ad09018c98f8c7f90646c47a2/sascha_haubner_headshot_article.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/therapeutics/mvp-insights_article-whitepaper-the-promises-and-perils-of-gene-editing-for</guid>
      <title><![CDATA[The Promises and Perils of Gene Editing for Sickle Cell]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/therapeutics/mvp-insights_article-whitepaper-the-promises-and-perils-of-gene-editing-for</link>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 05 Jun 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/6o9L72OYysN9OvdedWGM40/9f6a04069d72438a085ce90c2986fbc3/Sickle_Cells.jpg" medium="image" />
      <category>White Paper</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/ai-and-machine-learning/cell-and-gene-therapeutics/mvp-insights_article-3-changes-genomics-microscopes-bring-to-understanding</guid>
      <title><![CDATA[3 Changes Genomics Microscopes Bring to Understanding Disease]]></title>
      <link>https://wewillcure.com/insights/ai-and-machine-learning/cell-and-gene-therapeutics/mvp-insights_article-3-changes-genomics-microscopes-bring-to-understanding</link>
      <description><![CDATA[Trailblazing computational biologist Manolis Kellis, PhD, whose MIT laboratory works at the interface of computer science and biology, likens his work interface to a "genomics microscope."]]></description>
      <pubDate>Mon, 03 Jun 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/54hP1PHsu7WLAXANurrQzF/eb1ef048042f88229238e3ab1f725770/DNA_Profile.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/ai-and-machine-learning/cell-and-gene-therapeutics/mvp-insights_article-overriding-the-cellular-code-with-mrna-to-fight</guid>
      <title><![CDATA[Overriding the Cellular Code with mRNA to Fight Cancer]]></title>
      <link>https://wewillcure.com/insights/ai-and-machine-learning/cell-and-gene-therapeutics/mvp-insights_article-overriding-the-cellular-code-with-mrna-to-fight</link>
      <description><![CDATA[Chidiebere Awah, MD, PhD, CEO of UTR Therapeutics Inc., is developing a shelf-stable drug that targets, overrides and degrades the cellular signals driving cancer growth, and may apply to other diseases, such as Alzheimer's.]]></description>
      <pubDate>Mon, 03 Jun 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/2GztfGqN1KqI3bDPfqNP9G/648b5d5680f914ea72ddf84627b8017d/Isolated_RNA.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/ai-and-machine-learning/mvp-insights_article-report-chapter-biotechs-cutting-edge-in-2024</guid>
      <title><![CDATA[The New Players in Town]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/ai-and-machine-learning/mvp-insights_article-report-chapter-biotechs-cutting-edge-in-2024</link>
      <description><![CDATA[The overall biotech market is looking up, but in the ever-changing healthcare landscape, some areas are always hotter than others. At the height of the pandemic, for example, digital health and telehealth became booming industries. But now there are new players in town, reports Cure's Ready, Set, Growth! Biotech Benchmark Report 2024 survey. ]]></description>
      <pubDate>Mon, 03 Jun 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/pr6idX7VYb2NGtRTxhX4Y/dba2749dfae6e789c8853362aaf92f9e/biotech_pharma_molecule_markets.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/cell-and-gene-therapeutics/mvp-insights_article-a-harvard-medical-school-expert-on-why-we-should</guid>
      <title><![CDATA[A Harvard Medical School Expert on Why We Should Sequence All Babies’ Genomes]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/cell-and-gene-therapeutics/mvp-insights_article-a-harvard-medical-school-expert-on-why-we-should</link>
      <description><![CDATA[Robert C. Green  Director, Genomes2People and Precision Population Health Professor at Harvard Medical School, co-leads the first NIH-funded trials of genetic sequencing adults (MedSeq), newborns (BabySeq) and active-duty military personnel (MilSeq).]]></description>
      <pubDate>Fri, 03 May 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/1MgQLjiAm4TpqiXwvqNmBF/07ec49eba3079546459e4c37604bf40b/Your_Baby-s_Genome__The_Radical_Promise_of_Early_DNA_Testing_21_9.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/therapeutics/the-case-for-and-against-genetic-engineering</guid>
      <title><![CDATA[The Case for (and Against) Genetic Engineering]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/therapeutics/the-case-for-and-against-genetic-engineering</link>
      <description><![CDATA[Genetic engineering of dinosaurs isn't possible, yet the technology has yielded cancer therapies and just might help us travel in outer space. ]]></description>
      <pubDate>Wed, 13 Mar 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3OYzMEqkh5iQqTxJJ0vZGZ/6b908daa398b9f36934bfbb7550b0b7a/The_Case_for__and_Against__Genetic_Engineering_16_9.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/rare-diseases/gene-therapy-once-reserved-for-rare-single-gene-disorders-finds-a</guid>
      <title><![CDATA[Gene Therapy, Once Reserved for Rare Single-Gene Disorders, Finds a Place in Precision Medicine]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/rare-diseases/gene-therapy-once-reserved-for-rare-single-gene-disorders-finds-a</link>
      <description><![CDATA[What's ahead for gene therapy? R. Nolan Townsend, MBA, co-founded LEXEO Therapeutics to focus on bringing precision genetic medicines to patients with genetic cardiovascular diseases and Alzheimer’s.
]]></description>
      <pubDate>Fri, 01 Mar 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/2SRJ6ZykZuIGLM3fcNXpeu/af0ce4929f5e48f4645753ec3245e323/GettyImages-1442427705.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/founder-stories/spotlight-on-irene-rombel-phd-mba-co-founder-biocurie</guid>
      <title><![CDATA[Spotlight On: Irene Rombel, PhD, MBA, Co-founder, BioCurie]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/founder-stories/spotlight-on-irene-rombel-phd-mba-co-founder-biocurie</link>
      <description><![CDATA[With her co-founder Professor Richard Braatz, PhD, of MIT, Irene Rombel, PhD, MBA, aims to make innovative cell and gene therapies more accessible for people living with devastating rare diseases by overcoming the manufacturing dilemmas plaguing these treatments.]]></description>
      <pubDate>Tue, 20 Feb 2024 22:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/29b61KHxbazj7cBkEqXcU1/f1e07fca8a406ce81d90a660c3d24656/Biocurie_1920x1080.png" medium="image" />
      <category>Xchange Story</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/oncology/mvp-insights_article-making-sure-cells-dont-get-the-short-end-of-the-stick</guid>
      <title><![CDATA[Making Sure Cells Don't Get the Short End of the Stick]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/oncology/mvp-insights_article-making-sure-cells-dont-get-the-short-end-of-the-stick</link>
      <description><![CDATA[Pulitzer Prize-winning novelist and physician Siddhartha Mukherjee, MD, who has written entire books about genes, cancer and the laws of medicine, thought the cell should get one, too: "The Song of the Cell." ]]></description>
      <pubDate>Fri, 16 Feb 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/7rLfpXn8Q74FuGbVtP0YYz/60f4666e5976bccec4e7ef4aa18d64fe/thumbnail_organelles_illustration_GTY918985073.jpg" medium="image" />
      <category>Article</category>
    </item>
  </channel>
</rss>